Results 161 to 170 of about 1,438,843 (259)
Nanomaterial‐based immune therapeutic strategies in neurodegenerative diseases
This review highlights the immunomodulatory potential of nanomaterials (NMs) in treating neurodegenerative diseases (NDs). It focuses on their roles in regulating innate and adaptive immune responses to maintain immune homeostasis. By providing insights into these mechanisms, the review lays the groundwork for innovative NMs therapeutic strategies to ...
Xinru Zhou +6 more
wiley +1 more source
The burden of being certain: National identity certainty predicts support for COVID-Related restrictive measures and outgroup conspiracy beliefs. [PDF]
Chen K, Zhang J, Ao X, Ramdass J.
europepmc +1 more source
Northern Territory Anti-Discrimination Commission annual report 2003-2004
Date:2004This publication contains many links to external sites. These external sites may no longer be active.Made available by via the Publications (Legal Deposit) Act 2004 (NT)
core
This review comprehensively summarizes emerging biomaterial‐based strategies and underlying mechanisms for modulating endogenous tendon stem/progenitor cells (TSPCs). It offers the most recent insights into TSPC physiology and potential applications of tissue engineering and regenerative medicine in tendons.
Zeyu Zhu +9 more
wiley +1 more source
Malware and Disease: Lessons from Cyber Intelligence for Public Health Surveillance. [PDF]
Smith FL.
europepmc +1 more source
Mask-wearing intentions on airplanes during COVID-19 - Application of theory of planned behavior model. [PDF]
Pan JY, Liu D.
europepmc +1 more source
Protective Effect of Phytic Acid in Cardiovascular Diseases: A Systematic Review
ABSTRACT Cardiovascular diseases (CVDs) are a cluster of ailments that impact the heart and blood vessels and are a primary public health problem of mortality on a global scale. Phytic acid, a dietary constituent frequently present in foods like seeds, has been linked to many pharmacological attributes, including anti‐cancer, antioxidant, anti ...
Marta M. S. de Freitas Almeida +7 more
wiley +1 more source
ABSTRACT Inflammatory bowel disease (IBD), primarily Crohn's disease and ulcerative colitis, is a chronic relapsing inflammatory disorder of the gastrointestinal tract and an important risk factor for IBD‐associated cancer. Increasing evidence suggests that gut microbiota dysbiosis, epithelial barrier dysfunction, and immune microenvironment remodeling
Xue Zhang +4 more
wiley +1 more source
Demonstrating pharmacological effects in early‐phase oncology clinical trials remains challenging, largely due to the lack of robust pharmacodynamic markers. Lipopolysaccharide (LPS) is used as an immune challenge agent in healthy participants to study drugs for autoimmune conditions.
Igor Radanović +11 more
wiley +1 more source

